News
Paxton's office said the company supplied free nurses to help care for patients who received its drugs, as well as ...
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its ...
FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
Eli Lilly (LLY) stock in focus as Texas sues the company for alleged bribery related to weight loss drugs like Zepbound and ...
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...
Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results